Skip to content
Back to treatments
Regenerative Medicine~64% less than U.S.

Stem Cell Therapy for Joints

关节干细胞治疗

Duration
2-4 weeks for treatment; 6-12 months for full effect
Recovery
1-2 weeks post-injection rest; gradual return to activity over 6-8 weeks
Average savings
64%
价格对比Price comparison

China versus the U.S.

China
$10,000
Range: $5,000–$15,000
United States
$27,500
Range: $15,000–$40,000
You save
64%
~$17,500 per procedure
China clinical rate
$5,000 – $15,000
$10,000
United States
$15,000 – $40,000
$27,500
You save
~64%
$17,500 per procedure

Prices are approximate ranges. Actual cost depends on hospital, surgeon, materials, and case complexity.

关于About this treatment

What the procedure involves.

Autologous or allogeneic mesenchymal stem cell therapy for degenerative joint diseases including knee osteoarthritis and cartilage defects. Chinese regenerative medicine centers perform stem cell isolation, expansion, and intra-articular injection under strict GMP protocols. This therapy aims to regenerate cartilage, reduce inflammation, and delay or eliminate the need for joint replacement surgery.

流程Procedure steps

Step by step.

  1. 01

    Pre-treatment Assessment

    MRI imaging, cartilage grading, blood work, and eligibility screening for stem cell therapy

    Duration · 1-2 days
  2. 02

    Stem Cell Harvesting

    Bone marrow aspiration from iliac crest or adipose tissue liposuction under local anesthesia

    Duration · 1-2 hours
  3. 03

    Cell Processing & Expansion

    Laboratory isolation, characterization, and expansion of mesenchymal stem cells under GMP conditions

    Duration · 2-3 weeks
  4. 04

    Intra-articular Injection

    Ultrasound-guided injection of stem cells into affected joint(s) with post-procedure rehabilitation plan

    Duration · 30-60 minutes
Benefits
  • Potential to regenerate damaged cartilage tissue
  • May delay or eliminate need for joint replacement
  • Minimally invasive outpatient procedure
  • China's regulatory framework allows expanded access to stem cell therapies
Considerations
  • Variable efficacy — not all patients respond equally
  • Regulatory landscape differs from FDA-approved treatments
  • Potential for cell overgrowth or inappropriate differentiation
  • Limited long-term safety data for some protocols
下一步Next step

Ask the AI for hospitals that handle stem cell therapy for joints.

Ask AIRequest consultation

Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.